lobbying_filings_raw: e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86 | Q1 | 310973 | APOTEX CORP. | 183737 | APOTEX CORP. | 2010 | first_quarter | 2010-04-19T14:40:28.737000-04:00 | 130000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86/", "filing_uuid": "e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2010, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "130000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Steve Giuli, Director of Government Affairs & Industry Relations", "dt_posted": "2010-04-19T14:40:28.737000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "2400 N. COMMERCE PARKWAY", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WESTON", "registrant_state": "FL", "registrant_zip": "33326", "registrant": {"id": 310973, "url": "https://lda.senate.gov/api/v1/registrants/310973/", "house_registrant_id": 38623, "name": "APOTEX CORP.", "description": "Generic pharmaceutical manufacturer", "address_1": "2400 N. COMMERCE PARKWAY", "address_2": null, "address_3": null, "address_4": null, "city": "WESTON", "state": "FL", "state_display": "Florida", "zip": "33326", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "STEVE GIULI", "contact_telephone": "+1 954-384-8007", "dt_updated": "2026-01-30T15:29:14.471073-05:00"}, "client": {"id": 183737, "url": "https://lda.senate.gov/api/v1/clients/183737/", "client_id": 12, "name": "APOTEX CORP.", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "FL", "state_display": "Florida", "country": "US", "country_display": "United States of America", "ppb_state": "FL", "ppb_state_display": "Florida", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2006-07-20"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "S. 369, the Preserve Access to Affordable Pharmaceuticals Act\nS. 1315, the Drug Price Competition Act of 2009\nH.R. 3777, the Drug Price Competition Act of 2009\nH.R. 3962, Affordable Health Care for America Act, Section 2573, Protecting Consumer Access to Generic Drugs Act H.R. 3962, Affordable Heatlh Care for America Act, Section 2375, Licensure Pathway for Biosimilar Products\nH.R. 3590, the Patient Protection and Affordable Care Act, Title VII, Subtitle A, Biologics Price Competition and Innovation\nH.R. 4872, the Health Care and Education Reconciliation Act of 2010 pertaining to patent settlements between brand and generic pharmaceutical manufacturers", "foreign_entity_issues": "ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report", "lobbyists": [{"lobbyist": {"id": 41476, "prefix": null, "prefix_display": null, "first_name": "STEVEN", "nickname": null, "middle_name": null, "last_name": "GIULI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 64, "name": "Federal Trade Commission (FTC)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |